Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

248
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
248
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

573
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
573
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

237
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
237
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

3.7K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.7K
Ion Exchange01:17

Ion Exchange

1.3K
Ion exchange chromatography separates charged molecules from a solution by reversibly exchanging them with mobile, or 'active', ions associated with the oppositely charged stationary phase. This method can be used to separate ions, soften and deionize water, and purify solutions. The polymers comprising the ion-exchange column are high-molecular-weight and chemically stable polymers, crosslinked to be porous and essentially insoluble. They are also functionalized with either acidic or...
1.3K
Ion-Exchange Chromatography01:09

Ion-Exchange Chromatography

2.3K
Ion-exchange chromatography, or IEC, is a technique for separating ions based on their affinity for the stationary phase. The stationary phase is a cross-linked polymer resin with covalently attached ionic functional groups. The functional groups can be either positively charged (cation exchangers) or negatively charged (anion exchangers). A cation exchanger consists of a polymeric anion and active cations, while an anion exchanger is a polymeric cation with active anions. The choice of...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum cytokine profiling reveals distinct inflammatory signatures in Kawasaki disease and MIS-C and suggests associations with coronary artery lesions.

Pediatric research·2026
Same author

Cutaneous Magnetic Stimulation for Chronic Pain in Children: A Case Report.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.

Epidemiology and infection·2026
Same author

Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

Pediatric rheumatology online journal·2025
Same author

Juvenile idiopathic arthritis associated with Kabuki syndrome: A case report.

Pediatrics international : official journal of the Japan Pediatric Society·2025

Related Experiment Video

Updated: Feb 17, 2026

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.7K

[Plasma exchange therapy].

Masaaki Mori

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |December 19, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Plasma exchange (PE) offers effective early treatment for Kawasaki disease, preventing coronary lesions by removing inflammatory cytokines. This method shows significant promise, especially for IVIG-resistant cases, when initiated before coronary complications arise.

    More Related Videos

    Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
    09:22

    Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

    Published on: April 13, 2018

    17.4K
    Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
    05:23

    Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

    Published on: March 14, 2017

    20.5K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
    07:34

    Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

    Published on: August 3, 2022

    3.7K
    Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
    09:22

    Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

    Published on: April 13, 2018

    17.4K
    Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
    05:23

    Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

    Published on: March 14, 2017

    20.5K

    Area of Science:

    • Pediatric rheumatology
    • Immunology
    • Cardiology

    Context:

    • Kawasaki disease requires prompt treatment to prevent coronary artery lesions.
    • Early inflammation control is crucial for averting cardiac complications.
    • Intravenous immunoglobulin (IVIG) is a standard treatment, but resistance occurs.

    Purpose:

    • To evaluate the efficacy of plasma exchange (PE) in managing Kawasaki disease, particularly in IVIG-resistant cases.
    • To highlight PE's role in early inflammation suppression and prevention of coronary artery abnormalities.
    • To discuss the clinical utility of PE as an alternative therapy when other treatments fail.

    Summary:

    • Plasma exchange (PE) directly removes inflammatory cytokines and chemokines, effectively suppressing inflammation in Kawasaki disease.
    • PE demonstrates favorable outcomes in IVIG-resistant Kawasaki disease, especially when administered before the tenth day of illness to prevent coronary lesions.
    • The study suggests PE is a valuable therapeutic option, particularly when initial treatments like immunoglobulin therapy, steroid pulse therapy, or neutrophilic elastase inhibitor therapy are ineffective.

    Impact:

    • Early intervention with PE can significantly reduce the risk and severity of coronary artery aneurysms in Kawasaki disease patients.
    • PE provides a crucial treatment alternative for refractory Kawasaki disease, improving patient outcomes.
    • This approach supports timely and effective management, potentially lowering long-term cardiovascular morbidity in affected children.